KMB Stock Analysis: Kimberly-Clark | NASDAQ

Household & Personal Products | NASDAQ, USA | Market Cap: 37.354m USD | 12M Return: -5.6% | US4943681035 | Charts, Fundamentals & Technical Analysis

Diapers, Feminine Hygiene, Incontinence Care, Tissue Paper
Total Rating 49
Safety 70
Buy Signal -0.12
Household & Personal Products
Industry Rotation: +1.9
Market Cap: 37.4B
Avg Turnover: 465M
Risk 3d forecast
Volatility21.8%
VaR 5th Pctl3.73%
VaR vs Median3.73%
Reward TTM
Sharpe Ratio-0.19
Rel. Str. IBD48.2
Rel. Str. Peer Group37.5 pctl
Character TTM
Beta-0.117
Beta Downside-0.217
Hurst Exponent0.435
Choppyness62.6%
Drawdowns 3y
Max DD34.06%
CAGR/Max DD0.03
CAGR/Mean DD0.07
EPS (Earnings per Share) EPS (Earnings per Share) of KMB over the last years for every Quarter: "2021-09": 1.62, "2021-12": 1.3, "2022-03": 1.35, "2022-06": 1.34, "2022-09": 1.4, "2022-12": 1.54, "2023-03": 1.67, "2023-06": 1.65, "2023-09": 1.74, "2023-12": 1.51, "2024-03": 2.01, "2024-06": 1.96, "2024-09": 1.83, "2024-12": 1.5, "2025-03": 1.93, "2025-06": 1.92, "2025-09": 1.82, "2025-12": 1.86, "2026-03": 1.97, "2026-06": 1.8,
EPS CAGR: 4.45%
EPS Trend: 84.9%
Last SUE: -1.98
Qual. Beats: -1
Revenue Revenue of KMB over the last years for every Quarter: 2021-09: 5010, 2021-12: 4965, 2022-03: 5095, 2022-06: 5063, 2022-09: 5053, 2022-12: 4964, 2023-03: 5195, 2023-06: 5134, 2023-09: 5132, 2023-12: 4970, 2024-03: 5149, 2024-06: 4231, 2024-09: 4144, 2024-12: 4928, 2025-03: 4840, 2025-06: 4163, 2025-09: 4133, 2025-12: 4080, 2026-03: 4163, 2026-06: 4189,
Rev. CAGR: -7.86%
Rev. Trend: -97.4%
Last SUE: -0.06
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -0.5% 18
Feb +0.3% 7
Mar +0.9% 26
Apr +1.1% 10
May +0.0% 14
Jun +4.5% 52
Jul -0.1% 10
Aug +1.3% 17
Sep -1.9% 68
Oct -5.0% 53
Nov +3.6% 54
Dec -0.2% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: KMB Kimberly-Clark

Kimberly-Clark Corporation (NASDAQ: KMB) is a U.S.-based manufacturer of personal care products operating through two segments: North America and International Personal Care. The company sells both consumer household goods (diapers, training pants, baby wipes, feminine and incontinence care, facial tissue, paper towels, napkins, soaps, and sanitizers) and institutional products for offices, lodging, food service, and other high-volume facilities. Major brands include Huggies, Pull-Ups, Kotex, Depend, Kleenex, Scott, Cottonelle, and WypAll. Founded in 1872, Kimberly-Clark is headquartered in Dallas, Texas, and has traded on the NASDAQ since December 1984.

Kimberly-Clark operates within the Consumer Staples sector (GICS Sub Industry: Household Products), a defensive industry category characterized by relatively stable, non-cyclical demand for everyday essential goods. The household products subsector includes tissue, hygiene, and paper-based manufacturers that typically generate consistent revenue streams and prioritize brand loyalty, scale-driven cost efficiency, and broad retail distribution.

Headlines to Watch Out For
  • Volume softness persists despite pricing actions in North America
  • International Personal Care segment expands in emerging markets
  • Pulp and raw material costs pressure product gross margins
Piotroski VR-10 (Strict) 6.5
Net Income: 1.96b TTM > 0 and > 6% of Revenue
FCF/TA: 0.14 > 0.02 and ΔFCF/TA 1.27 > 1.0
NWC/Revenue: -3.83% < 20% (prev -8.93%; Δ 5.10% < -1%)
CFO/TA 0.18 > 3% & CFO 3.33b > Net Income 1.96b
Net Debt (5.69b) to EBITDA (3.19b): 1.78 < 3
Current Ratio: 0.91 > 1.5 & < 3
Outstanding Shares: last quarter (333.3m) vs 12m ago 0.0% < -2%
Gross Margin: 36.69% > 18% (prev 35.56%; Δ 1.13% > 0.5%)
Asset Turnover: 93.79% > 50% (prev 107.8%; Δ -13.99% > 0%)
Interest Coverage Ratio: 10.44 > 6 (EBIT TTM 2.46b / Interest Expense TTM 236.0m)
Altman Z'' 2.54
A: -0.03 (Total Current Assets 6.35b - Total Current Liabilities 6.99b) / Total Assets 18.6b
B: 0.53 (Retained Earnings 9.77b / Total Assets 18.6b)
C: 0.14 (EBIT TTM 2.46b / Avg Total Assets 17.7b)
D: 0.11 (Book Value of Equity 1.75b / Total Liabilities 16.7b)
Altman-Z'' = 2.54 = A
Beneish M -3.13
DSRI: 1.01 (Receivables 1.86b/2.01b, Revenue 16.6b/18.1b)
GMI: 0.97 (GM 35.56% / 36.69%)
AQI: 0.97 (AQ_t 0.28 / AQ_t-1 0.29)
SGI: 0.92 (Revenue 16.6b / 18.1b)
TATA: -0.07 (NI 1.96b - CFO 3.33b) / TA 18.6b)
Beneish M = -3.13 (Cap -4..+1) = AA
What is the price of KMB shares?

As of October 29, 2026, the stock is trading at USD 108.40 with a total of 3,080,975 shares traded. Over the past week, the price has changed by +1.65%, over one month by +9.75%, over three months by -3.00% and over the past year by -5.56%.

Current recommended Stop Loss: 104.80 (which is 3.3% or 1.5 ATR below the current price).

Is KMB a buy, sell or hold?

Kimberly-Clark has received a consensus analysts rating of 3.56. Therefore, it is recommended to hold KMB.

  • StrongBuy: 4
  • Buy: 3
  • Hold: 8
  • Sell: 0
  • StrongSell: 1

What are the forecasts/targets for the KMB price?
Analysts Target Price 114.8 5.9%
Kimberly-Clark (KMB) - Fundamental Data Overview as of 24 October 2026
Market Cap USD = 37.4b (37.4b USD * 1.0 USD.USD)
P/E Trailing = 21.0328
P/E Forward = 13.1406
P/S = 2.2527
P/B = 18.7974
P/EG = 2.0208
Revenue TTM = 16.6b USD
EBIT TTM = 2.46b USD
EBITDA TTM = 3.19b USD
Long Term Debt = 6.47b USD (from longTermDebt, last quarter)
Short Term Debt = 43.0m USD (from shortTermDebt, last quarter)
Debt = 6.64b USD (from shortLongTermDebtTotal, last quarter) + Leases 128.0m
Net Debt = 5.69b USD (calculated: Debt 6.64b - CCE 956.0m)
Enterprise Value = 43.0b USD (37.4b + Debt 6.64b - CCE 956.0m)
Interest Coverage Ratio = 10.44 (Ebit TTM 2.46b / Interest Expense TTM 236.0m)
EV/FCF = 16.81x (Enterprise Value 43.0b / FCF TTM 2.56b)
FCF Yield = 5.95% (FCF TTM 2.56b / Enterprise Value 43.0b)
FCF Margin = 15.46% (FCF TTM 2.56b / Revenue TTM 16.6b)
Net Margin = 11.80% (Net Income TTM 1.96b / Revenue TTM 16.6b)
Gross Margin = 36.69% ((Revenue TTM 16.6b - Cost of Revenue TTM 10.5b) / Revenue TTM)
Gross Margin QoQ = 38.27% (prev 36.85%)
Tobins Q-Ratio = 2.32 (Enterprise Value 43.0b / Total Assets 18.6b)
Interest Expense / Debt = 3.55% (Interest Expense 236.0m / Debt 6.64b)
Taxrate = 29.50% (674.0m / 2.29b)
NOPAT = 1.74b (EBIT 2.46b * (1 - 29.50%))
Current Ratio = 0.91 (Total Current Assets 6.35b / Total Current Liabilities 6.99b)
Debt / Equity = 3.80 (Debt 6.64b / totalStockholderEquity, last quarter 1.75b)
Debt / EBITDA = 1.78 (Net Debt 5.69b / EBITDA 3.19b)
Debt / FCF = 2.22 (Net Debt 5.69b / FCF TTM 2.56b)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.07% (Net Income 1.96b / Total Assets 18.6b)
RoE = 122.6% (Net Income TTM 1.96b / Total Stockholder Equity 1.59b)
RoCE = 30.52% (EBIT 2.46b / Capital Employed (Equity 1.59b + L.T.Debt 6.47b))
RoIC = 16.11% (NOPAT 1.74b / Invested Capital 10.8b)
WACC = 4.84% (E(37.4b)/V(44.0b) * Re(5.26%) + D(6.64b)/V(44.0b) * Rd(3.55%) * (1-Tc(0.29)))
Discount Rate = 5.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.14 | Cagr: -0.66%
[DCF] Terminal Value 77.97% ; FCFF base≈2.38b ; Y1≈2.73b ; Y5≈4.01b
[DCF] Fair Price = 164.4 (EV 60.4b - Net Debt 5.69b = Equity 54.7b / Shares 332.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 84.89 | EPS CAGR: 4.45% | SUE: -1.98 | # QB: -1
Revenue Correlation: -97.37 | Revenue CAGR: -7.86% | SUE: -0.06 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.63 | Chg30d=+1.79% | Revisions=-62% | Analysts=13
EPS current Year (2026-12-31): EPS=7.38 | Chg30d=-0.11% | Revisions=-75% | GrowthEPS=-2.0% | GrowthRev=+0.9%
EPS next Year (2027-12-31): EPS=7.41 | Chg30d=-1.00% | Revisions=-67% | GrowthEPS=+0.3% | GrowthRev=+2.6%
[Analyst] Revisions Ratio: -82% (up=1, down=24)